Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pradaxa vs aspirin for secondary prevention after ESUS
CTR20160278Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dabigatran in embolic stroke of undetermined source (ESUS), sponsored by Boehringer Ingelheim. Started Jun 2016; status: completed.
02
Drugs
dabigatran
03
Conditions
embolic stroke of undetermined source (ESUS)
Beyond the preview
Go deeper on CTR20160278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160278.